Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)

Clinical trial NCT03031418 · COMPLETED

Trial details

NCT number: NCT03031418
Sponsor: Exosome Diagnostics, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer of Prostate

Start date: 2016-09-01
Primary completion: 2018-09-01
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.